These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25489988)

  • 1. The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice.
    Sapra G; Tham YK; Cemerlang N; Matsumoto A; Kiriazis H; Bernardo BC; Henstridge DC; Ooi JY; Pretorius L; Boey EJ; Lim L; Sadoshima J; Meikle PJ; Mellet NA; Woodcock EA; Marasco S; Ueyama T; Du XJ; Febbraio MA; McMullen JR
    Nat Commun; 2014 Dec; 5():5705. PubMed ID: 25489988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats.
    Horvath O; Ordog K; Bruszt K; Deres L; Gallyas F; Sumegi B; Toth K; Halmosi R
    Oxid Med Cell Longev; 2021; 2021():1250858. PubMed ID: 33564362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I.
    Matthews LC; Taggart MJ; Westwood M
    Endocrinology; 2008 Oct; 149(10):5199-208. PubMed ID: 18583416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation.
    Bernardo BC; Sapra G; Patterson NL; Cemerlang N; Kiriazis H; Ueyama T; Febbraio MA; McMullen JR
    PLoS One; 2015; 10(12):e0145173. PubMed ID: 26660322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease: Insulin sensitizer protects the heart.
    Crunkhorn S
    Nat Rev Drug Discov; 2015 Feb; 14(2):93. PubMed ID: 25633791
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
    J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease.
    Zhang P; Wang W; Wang X; Wang X; Song Y; Zhang J; Zhao H
    Int J Cardiol; 2013 Oct; 168(4):3200-7. PubMed ID: 23639457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different small HSPB members on contractile dysfunction and structural changes in a Drosophila melanogaster model for Atrial Fibrillation.
    Zhang D; Ke L; Mackovicova K; Van Der Want JJ; Sibon OC; Tanguay RM; Morrow G; Henning RH; Kampinga HH; Brundel BJ
    J Mol Cell Cardiol; 2011 Sep; 51(3):381-9. PubMed ID: 21745477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.
    Pretorius L; Du XJ; Woodcock EA; Kiriazis H; Lin RC; Marasco S; Medcalf RL; Ming Z; Head GA; Tan JW; Cemerlang N; Sadoshima J; Shioi T; Izumo S; Lukoshkova EV; Dart AM; Jennings GL; McMullen JR
    Am J Pathol; 2009 Sep; 175(3):998-1009. PubMed ID: 19679877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial fibrillation in patients with heart failure: treatment and management].
    Shiga T
    Nihon Rinsho; 2013 Jan; 71(1):131-5. PubMed ID: 23631184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial fibrillation and heart failure: a dangerous criminal conspiracy].
    Piot O
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S14-6. PubMed ID: 20103171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation in heart failure.
    Lardizabal JA; Deedwania PC
    Med Clin North Am; 2012 Sep; 96(5):987-1000. PubMed ID: 22980060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
    Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
    Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients.
    Puglisi A; Gasparini M; Lunati M; Sassara M; Padeletti L; Landolina M; Botto GL; Vincenti A; Bianchi S; Denaro A; Grammatico A; Boriani G;
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):693-701. PubMed ID: 18328039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling by insulin and IGF receptors: supporting acts and new players.
    Siddle K
    J Mol Endocrinol; 2011 Aug; 47(1):R1-10. PubMed ID: 21498522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation.
    Lu Y; Zhang Y; Wang N; Pan Z; Gao X; Zhang F; Zhang Y; Shan H; Luo X; Bai Y; Sun L; Song W; Xu C; Wang Z; Yang B
    Circulation; 2010 Dec; 122(23):2378-87. PubMed ID: 21098446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.